Tao Capital Management LP holds a concentrated book of 6 stocks worth $1.9B as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). This quarter they opened Space Exploration Techn-CL A and trimmed Twist Bioscience Corp. Their largest long position is Space Exploration Techn-CL A at 94% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
6% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Tao Capital Management LP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Capricorn Investment Group LLC | 2 / 6 | $20.7B |
| Dan Sundheim | 2 / 6 | $21.7B |
| Sloy Dahl & Holst, LLC | 2 / 6 | $438.2M |
| Aspiring Ventures, LLC | 2 / 6 | $217.9M |
| Halter Ferguson Financial Inc. | 2 / 6 | $265.0M |
| Nightview Capital, LLC | 2 / 6 | $47.7M |
| Atreides Management, LP | 2 / 6 | $4.8B |
| Tsai Capital Corp | 2 / 6 | $36.3M |
Ranked by the share of each fund's own book sitting in the names it shares with Tao Capital Management LP: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Space Exploration Technologies Corp. Class A Common Stock | $1.8B | 10.64M | 93.7% | ▲New New position | |
| 2 | Twist Bioscience Corporation Common Stock | $49.3M | 478.8K | 2.5% | ▼−42% Reduced · −350K sh | |
| 3 | Tesla, Inc. Common Stock | $36.3M | 86.3K | 1.9% | —Held | |
| 4 | Hyatt Hotels Corporation Class B Common Stock | $13.6M | 70.0K | 0.7% | —Held | |
| 5 | Madrigal Pharmaceuticals, Inc. Common Stock | $11.3M | 21.0K | 0.6% | —Held | |
| 6 | 10x Genomics, Inc. Class A Common Stock | $10.9M | 283.5K | 0.6% | ▲+34% Added · +73K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1802967/holdings"
Use Arkolith to show Tao Capital Management LP's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.